Regeneron Pharmaceuticals
REGN
#252
Rank
โ‚ฌ84.71 B
Marketcap
818,95ย โ‚ฌ
Share price
1.73%
Change (1 day)
44.39%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): 34,71ย โ‚ฌ

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 37,31ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 36,07ย โ‚ฌ a decrease over its 2021 EPS that were of 68,06ย โ‚ฌ.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)34,71ย โ‚ฌ-3.77%
202236,07ย โ‚ฌ-47%
202168,06ย โ‚ฌ133.36%
202029,16ย โ‚ฌ69.13%
201917,24ย โ‚ฌ-14.44%
201820,15ย โ‚ฌ100.71%
201710,04ย โ‚ฌ31.78%
20167,62ย โ‚ฌ38.96%
20155,48ย โ‚ฌ72.55%
20143,18ย โ‚ฌ-17.55%
20133,85ย โ‚ฌ-44.98%
20127,01ย โ‚ฌ-422.54%
2011-2,17ย โ‚ฌ92.13%
2010-1,13ย โ‚ฌ49.41%
2009-0,76ย โ‚ฌ-15.84%
2008-0,90ย โ‚ฌ-36.88%
2007-1,42ย โ‚ฌ-9.6%
2006-1,58ย โ‚ฌ4.12%
2005-1,51ย โ‚ฌ-323.68%
20040,68ย โ‚ฌ-135.51%
2003-1,91ย โ‚ฌ-24.38%
2002-2,52ย โ‚ฌ56.35%
2001-1,61ย โ‚ฌ187.3%
2000-0,56ย โ‚ฌ-11.26%
1999-0,63ย โ‚ฌ177.78%
1998-0,23ย โ‚ฌ-35.71%
1997-0,35ย โ‚ฌ-68.42%
1996-1,12ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
5,95ย โ‚ฌ-84.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,67ย โ‚ฌ-87.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
14,44ย โ‚ฌ-61.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,69ย โ‚ฌ-95.46%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
2,10ย โ‚ฌ-94.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
17,63ย โ‚ฌ-52.73%๐Ÿ‡บ๐Ÿ‡ธ USA